Mark Allen Peppercorn, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 32 | 2014 | 1921 | 1.580 |
Why?
|
| Mesalamine | 16 | 2008 | 135 | 1.230 |
Why?
|
| Crohn Disease | 32 | 2014 | 2279 | 1.090 |
Why?
|
| Inflammatory Bowel Diseases | 15 | 2014 | 2423 | 0.890 |
Why?
|
| Gastrointestinal Agents | 8 | 2011 | 510 | 0.860 |
Why?
|
| Aminosalicylic Acids | 13 | 2002 | 37 | 0.600 |
Why?
|
| Immunosuppressive Agents | 9 | 2014 | 4189 | 0.440 |
Why?
|
| Sulfasalazine | 13 | 1995 | 84 | 0.410 |
Why?
|
| Adrenal Cortex Hormones | 7 | 2008 | 1878 | 0.280 |
Why?
|
| Anti-Inflammatory Agents | 6 | 2010 | 1812 | 0.280 |
Why?
|
| Proctocolectomy, Restorative | 3 | 2000 | 190 | 0.280 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2014 | 4340 | 0.270 |
Why?
|
| Ileostomy | 2 | 2000 | 121 | 0.270 |
Why?
|
| Immunologic Factors | 3 | 2014 | 1589 | 0.260 |
Why?
|
| Celiac Disease | 2 | 2011 | 819 | 0.250 |
Why?
|
| Antibodies, Monoclonal | 7 | 2011 | 9185 | 0.230 |
Why?
|
| Diverticulum | 1 | 2004 | 137 | 0.210 |
Why?
|
| Anti-Ulcer Agents | 2 | 2002 | 112 | 0.200 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2006 | 2270 | 0.200 |
Why?
|
| Epilepsies, Partial | 1 | 2005 | 431 | 0.190 |
Why?
|
| Carcinoma, Papillary | 1 | 2006 | 785 | 0.180 |
Why?
|
| Sigmoid Diseases | 3 | 2004 | 59 | 0.170 |
Why?
|
| Enema | 5 | 2006 | 141 | 0.160 |
Why?
|
| Abdominal Pain | 3 | 2005 | 1071 | 0.160 |
Why?
|
| Drug Therapy, Combination | 5 | 2014 | 6305 | 0.160 |
Why?
|
| Pregnancy Complications | 2 | 2006 | 2948 | 0.160 |
Why?
|
| Intestinal Diseases | 3 | 1994 | 503 | 0.120 |
Why?
|
| Colitis | 5 | 2004 | 1234 | 0.120 |
Why?
|
| Enalapril | 2 | 1994 | 310 | 0.120 |
Why?
|
| Fertility | 1 | 1999 | 768 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 7 | 2011 | 7405 | 0.110 |
Why?
|
| Administration, Topical | 5 | 2006 | 703 | 0.110 |
Why?
|
| Humans | 91 | 2014 | 761098 | 0.100 |
Why?
|
| Angioedema | 1 | 1994 | 184 | 0.100 |
Why?
|
| Diverticulum, Colon | 1 | 1992 | 32 | 0.100 |
Why?
|
| Thyroid Neoplasms | 1 | 2006 | 2331 | 0.100 |
Why?
|
| Ciprofloxacin | 1 | 1993 | 312 | 0.100 |
Why?
|
| Homosexuality | 2 | 1982 | 267 | 0.090 |
Why?
|
| Fecal Incontinence | 1 | 1993 | 242 | 0.090 |
Why?
|
| Colectomy | 3 | 2008 | 686 | 0.090 |
Why?
|
| Cellulitis | 1 | 2011 | 208 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 17889 | 0.080 |
Why?
|
| Administration, Oral | 5 | 2006 | 4014 | 0.080 |
Why?
|
| Drug Resistance | 2 | 2008 | 1594 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 1999 | 2920 | 0.070 |
Why?
|
| Leukapheresis | 1 | 2008 | 134 | 0.070 |
Why?
|
| Sublingual Gland | 1 | 1987 | 11 | 0.070 |
Why?
|
| Salivary Gland Diseases | 1 | 1987 | 37 | 0.070 |
Why?
|
| Sialadenitis | 1 | 1987 | 45 | 0.070 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 1990 | 618 | 0.070 |
Why?
|
| Esophagus | 2 | 1989 | 1033 | 0.060 |
Why?
|
| Adult | 38 | 2011 | 221083 | 0.060 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1989 | 388 | 0.060 |
Why?
|
| Barrett Esophagus | 1 | 1989 | 492 | 0.060 |
Why?
|
| Pouchitis | 1 | 2006 | 64 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 1997 | 2528 | 0.060 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 2000 | 219 | 0.060 |
Why?
|
| Cyclosporine | 1 | 2008 | 776 | 0.060 |
Why?
|
| Central Nervous System Diseases | 1 | 1989 | 521 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 1988 | 2157 | 0.060 |
Why?
|
| Granuloma | 1 | 1987 | 327 | 0.060 |
Why?
|
| Esophageal Neoplasms | 3 | 1994 | 1658 | 0.060 |
Why?
|
| Biological Products | 1 | 2014 | 913 | 0.060 |
Why?
|
| Female | 45 | 2011 | 392458 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2008 | 961 | 0.060 |
Why?
|
| Tacrolimus | 1 | 2008 | 735 | 0.060 |
Why?
|
| Cinnamates | 3 | 1974 | 59 | 0.060 |
Why?
|
| Colon, Sigmoid | 1 | 2004 | 124 | 0.060 |
Why?
|
| Azathioprine | 2 | 2000 | 354 | 0.050 |
Why?
|
| Treatment Outcome | 11 | 2014 | 64670 | 0.050 |
Why?
|
| Phenytoin | 2 | 1980 | 190 | 0.050 |
Why?
|
| Phenylhydrazines | 1 | 2002 | 28 | 0.050 |
Why?
|
| Diverticulitis, Colonic | 1 | 2004 | 138 | 0.050 |
Why?
|
| Fistula | 1 | 2004 | 212 | 0.050 |
Why?
|
| Peptic Ulcer | 1 | 1983 | 217 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 2 | 2004 | 988 | 0.050 |
Why?
|
| Severity of Illness Index | 7 | 2003 | 15845 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 1995 | 1116 | 0.050 |
Why?
|
| Psychology | 1 | 2003 | 356 | 0.050 |
Why?
|
| Diverticulitis | 1 | 2004 | 185 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2010 | 10213 | 0.050 |
Why?
|
| Diagnosis, Differential | 6 | 2005 | 12975 | 0.050 |
Why?
|
| Glucocorticoids | 3 | 1997 | 2160 | 0.040 |
Why?
|
| Probiotics | 1 | 2004 | 378 | 0.040 |
Why?
|
| Middle Aged | 24 | 2011 | 220835 | 0.040 |
Why?
|
| Organometallic Compounds | 1 | 1983 | 647 | 0.040 |
Why?
|
| Bacteria | 6 | 1975 | 2190 | 0.040 |
Why?
|
| Intestines | 6 | 1975 | 1908 | 0.040 |
Why?
|
| Surgical Stapling | 1 | 2000 | 98 | 0.040 |
Why?
|
| Abdomen | 2 | 2011 | 1128 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 3725 | 0.040 |
Why?
|
| Aged | 18 | 2010 | 169266 | 0.040 |
Why?
|
| Male | 35 | 2011 | 360675 | 0.040 |
Why?
|
| Steroids | 3 | 1999 | 929 | 0.040 |
Why?
|
| Clinical Trials as Topic | 4 | 2008 | 8000 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2003 | 642 | 0.040 |
Why?
|
| Hydrocortisone | 2 | 2003 | 1818 | 0.040 |
Why?
|
| Recurrence | 6 | 2003 | 8456 | 0.040 |
Why?
|
| Ileum | 1 | 2000 | 557 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2008 | 2687 | 0.040 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 1998 | 101 | 0.040 |
Why?
|
| Germ-Free Life | 4 | 1974 | 186 | 0.030 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1982 | 662 | 0.030 |
Why?
|
| Self-Help Groups | 1 | 1998 | 192 | 0.030 |
Why?
|
| Intestinal Mucosa | 6 | 1995 | 3030 | 0.030 |
Why?
|
| Intestinal Absorption | 4 | 1995 | 400 | 0.030 |
Why?
|
| Thorax | 1 | 1979 | 555 | 0.030 |
Why?
|
| Interleukins | 1 | 2001 | 782 | 0.030 |
Why?
|
| Prednisone | 1 | 2000 | 1565 | 0.030 |
Why?
|
| Metronidazole | 2 | 1990 | 232 | 0.030 |
Why?
|
| Animals | 11 | 2010 | 168083 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 1999 | 628 | 0.030 |
Why?
|
| Remission Induction | 3 | 2010 | 2392 | 0.030 |
Why?
|
| Body Composition | 1 | 2003 | 2427 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 1982 | 1201 | 0.030 |
Why?
|
| Pain | 2 | 1979 | 5070 | 0.030 |
Why?
|
| Ileitis | 1 | 1993 | 39 | 0.030 |
Why?
|
| Interleukin-1 | 2 | 2001 | 1250 | 0.030 |
Why?
|
| Pregnancy | 4 | 2006 | 29872 | 0.030 |
Why?
|
| Melena | 1 | 1993 | 32 | 0.030 |
Why?
|
| Deglutition Disorders | 1 | 1979 | 627 | 0.030 |
Why?
|
| Hepatitis B | 2 | 1982 | 704 | 0.030 |
Why?
|
| Anemia, Refractory | 1 | 1992 | 17 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 1995 | 249 | 0.030 |
Why?
|
| Carcinoid Tumor | 1 | 1994 | 224 | 0.030 |
Why?
|
| Oxyuriasis | 2 | 1982 | 2 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2002 | 10755 | 0.030 |
Why?
|
| Lymphogranuloma Venereum | 2 | 1982 | 14 | 0.030 |
Why?
|
| Campylobacter Infections | 2 | 1982 | 31 | 0.030 |
Why?
|
| Risk Factors | 6 | 2007 | 74219 | 0.030 |
Why?
|
| Giardiasis | 2 | 1982 | 28 | 0.030 |
Why?
|
| Prednisolone | 1 | 1993 | 324 | 0.030 |
Why?
|
| Condylomata Acuminata | 2 | 1982 | 75 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 1989 | 6340 | 0.020 |
Why?
|
| Prognosis | 4 | 2004 | 29672 | 0.020 |
Why?
|
| Anemia, Sideroblastic | 1 | 1992 | 109 | 0.020 |
Why?
|
| Sigmoidoscopy | 1 | 1992 | 151 | 0.020 |
Why?
|
| Dysentery, Bacillary | 2 | 1982 | 73 | 0.020 |
Why?
|
| Colonoscopy | 2 | 1997 | 1398 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 1999 | 1182 | 0.020 |
Why?
|
| Prenatal Care | 1 | 1999 | 1141 | 0.020 |
Why?
|
| Digestive System | 1 | 1971 | 244 | 0.020 |
Why?
|
| Salmonella Infections | 2 | 1982 | 172 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1993 | 15634 | 0.020 |
Why?
|
| Antibodies | 2 | 2003 | 2415 | 0.020 |
Why?
|
| Suppositories | 2 | 1993 | 16 | 0.020 |
Why?
|
| Proctitis | 2 | 1983 | 40 | 0.020 |
Why?
|
| Aeromonas | 1 | 1989 | 16 | 0.020 |
Why?
|
| Ethacrynic Acid | 1 | 1969 | 7 | 0.020 |
Why?
|
| Syphilis | 2 | 1982 | 243 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2011 | 445 | 0.020 |
Why?
|
| Time Factors | 4 | 2003 | 39953 | 0.020 |
Why?
|
| HLA-B8 Antigen | 1 | 1988 | 16 | 0.020 |
Why?
|
| HLA-DR3 Antigen | 1 | 1988 | 24 | 0.020 |
Why?
|
| Herpes Simplex | 2 | 1982 | 465 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2000 | 2030 | 0.020 |
Why?
|
| Emergencies | 1 | 1995 | 1217 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2010 | 883 | 0.020 |
Why?
|
| Gonorrhea | 2 | 1982 | 346 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 1995 | 1891 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1995 | 1837 | 0.020 |
Why?
|
| Bacterial Infections | 2 | 1989 | 1390 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 2001 | 3210 | 0.020 |
Why?
|
| Smoking | 1 | 2004 | 9055 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1988 | 606 | 0.020 |
Why?
|
| Nausea | 1 | 1989 | 679 | 0.020 |
Why?
|
| Safety | 1 | 2010 | 1151 | 0.020 |
Why?
|
| Neutropenia | 1 | 1991 | 885 | 0.020 |
Why?
|
| Drug Interactions | 2 | 1984 | 1417 | 0.020 |
Why?
|
| Feces | 5 | 1989 | 1490 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1996 | 1909 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2010 | 2217 | 0.020 |
Why?
|
| Sulfapyridine | 2 | 1995 | 5 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 1187 | 0.020 |
Why?
|
| Colon | 2 | 1992 | 1791 | 0.020 |
Why?
|
| Deafness | 1 | 1969 | 459 | 0.010 |
Why?
|
| Liver | 1 | 1980 | 7513 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 3 | 1973 | 213 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 2 | 1974 | 74 | 0.010 |
Why?
|
| Carbenoxolone | 1 | 1983 | 8 | 0.010 |
Why?
|
| Sucralfate | 1 | 1983 | 12 | 0.010 |
Why?
|
| Esophageal Perforation | 1 | 1984 | 65 | 0.010 |
Why?
|
| Decision Making | 1 | 1998 | 3925 | 0.010 |
Why?
|
| Edema | 1 | 1988 | 765 | 0.010 |
Why?
|
| Neutrophils | 2 | 1995 | 3763 | 0.010 |
Why?
|
| Cimetidine | 1 | 1983 | 76 | 0.010 |
Why?
|
| Bismuth | 1 | 1983 | 29 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1995 | 5478 | 0.010 |
Why?
|
| Risk Assessment | 3 | 2003 | 24013 | 0.010 |
Why?
|
| Chemistry | 2 | 1975 | 324 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 1983 | 88 | 0.010 |
Why?
|
| Cholestyramine Resin | 1 | 1983 | 25 | 0.010 |
Why?
|
| Chemical Phenomena | 2 | 1975 | 483 | 0.010 |
Why?
|
| Antacids | 1 | 1983 | 94 | 0.010 |
Why?
|
| Adolescent | 5 | 2011 | 88271 | 0.010 |
Why?
|
| Campylobacter fetus | 1 | 1982 | 6 | 0.010 |
Why?
|
| Antidiarrheals | 1 | 1983 | 46 | 0.010 |
Why?
|
| Canada | 1 | 1988 | 2125 | 0.010 |
Why?
|
| Gene Expression | 2 | 1995 | 7567 | 0.010 |
Why?
|
| Epilepsy | 1 | 1978 | 3304 | 0.010 |
Why?
|
| Aluminum | 1 | 1983 | 152 | 0.010 |
Why?
|
| Aged, 80 and over | 5 | 2010 | 58946 | 0.010 |
Why?
|
| Entamoebiasis | 1 | 1982 | 12 | 0.010 |
Why?
|
| Multivariate Analysis | 3 | 2003 | 12058 | 0.010 |
Why?
|
| Lactobacillus | 3 | 1974 | 212 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1988 | 1331 | 0.010 |
Why?
|
| Diarrhea | 1 | 1989 | 1318 | 0.010 |
Why?
|
| Autoimmune Diseases | 2 | 1991 | 2243 | 0.010 |
Why?
|
| Mast Cells | 2 | 1995 | 1392 | 0.010 |
Why?
|
| Acute Disease | 1 | 1993 | 7240 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1997 | 11118 | 0.010 |
Why?
|
| Neisseria meningitidis | 1 | 1982 | 108 | 0.010 |
Why?
|
| Premedication | 1 | 1983 | 246 | 0.010 |
Why?
|
| Histamine H2 Antagonists | 1 | 1983 | 166 | 0.010 |
Why?
|
| Biotransformation | 2 | 1972 | 166 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1984 | 461 | 0.010 |
Why?
|
| Hepatitis A | 1 | 1982 | 127 | 0.010 |
Why?
|
| Amebiasis | 1 | 1982 | 33 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2002 | 6919 | 0.010 |
Why?
|
| Meningitis, Meningococcal | 1 | 1982 | 43 | 0.010 |
Why?
|
| Streptococcus | 2 | 1972 | 197 | 0.010 |
Why?
|
| Bacteroides | 2 | 1972 | 165 | 0.010 |
Why?
|
| Europe | 1 | 1988 | 3422 | 0.010 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 1982 | 64 | 0.010 |
Why?
|
| Mass Screening | 1 | 1997 | 5425 | 0.010 |
Why?
|
| Biopsy | 4 | 1993 | 6781 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1995 | 12743 | 0.010 |
Why?
|
| Disease Progression | 1 | 1998 | 13506 | 0.010 |
Why?
|
| Vasopressins | 1 | 1982 | 351 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 1376 | 0.010 |
Why?
|
| New England | 1 | 2003 | 1050 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 1983 | 603 | 0.010 |
Why?
|
| United States | 2 | 2004 | 72337 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1984 | 2262 | 0.010 |
Why?
|
| Tuberculosis | 1 | 1973 | 2015 | 0.010 |
Why?
|
| Interleukin-15 | 1 | 2001 | 185 | 0.010 |
Why?
|
| Foreign Bodies | 1 | 1984 | 402 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2004 | 10083 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 1995 | 10203 | 0.010 |
Why?
|
| Milk, Human | 1 | 1984 | 486 | 0.010 |
Why?
|
| Blood Sedimentation | 1 | 2001 | 235 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 1818 | 0.010 |
Why?
|
| Electroencephalography | 2 | 1989 | 6242 | 0.010 |
Why?
|
| Spasm | 1 | 1979 | 130 | 0.010 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2004 | 571 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1982 | 548 | 0.010 |
Why?
|
| Anus Neoplasms | 1 | 1982 | 329 | 0.010 |
Why?
|
| Thyroxine-Binding Proteins | 1 | 1998 | 24 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 2278 | 0.010 |
Why?
|
| Chlamydia Infections | 1 | 1982 | 364 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1978 | 384 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 2478 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2004 | 1472 | 0.010 |
Why?
|
| Cecum | 3 | 1974 | 234 | 0.010 |
Why?
|
| Thyroglobulin | 1 | 1998 | 111 | 0.010 |
Why?
|
| Retrospective Studies | 4 | 2011 | 80673 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 2873 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1985 | 4849 | 0.010 |
Why?
|
| Esophagitis, Peptic | 1 | 1978 | 76 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 3419 | 0.010 |
Why?
|
| Papilloma | 1 | 1978 | 140 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1979 | 347 | 0.010 |
Why?
|
| Manometry | 1 | 1979 | 453 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 2003 | 8519 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1992 | 9317 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2000 | 982 | 0.010 |
Why?
|
| Angiography | 1 | 1982 | 1597 | 0.010 |
Why?
|
| Platelet Count | 1 | 1999 | 782 | 0.010 |
Why?
|
| Dilatation | 1 | 1978 | 307 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12727 | 0.010 |
Why?
|
| Neomycin | 2 | 1974 | 92 | 0.010 |
Why?
|
| Cardiac Output, Low | 1 | 1997 | 191 | 0.010 |
Why?
|
| Autoantibodies | 2 | 1998 | 2117 | 0.010 |
Why?
|
| Necrosis | 1 | 1980 | 1611 | 0.010 |
Why?
|
| Logistic Models | 2 | 2003 | 13254 | 0.010 |
Why?
|
| Hypokalemia | 1 | 1997 | 153 | 0.010 |
Why?
|
| Longitudinal Studies | 2 | 2003 | 14607 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2004 | 12341 | 0.010 |
Why?
|
| Mental Processes | 1 | 1997 | 244 | 0.010 |
Why?
|
| Laser Therapy | 1 | 1982 | 1094 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1982 | 955 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 383 | 0.010 |
Why?
|
| Rats | 5 | 1974 | 23713 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1998 | 834 | 0.010 |
Why?
|
| Young Adult | 2 | 2011 | 59199 | 0.010 |
Why?
|
| Enterococcus faecalis | 2 | 1974 | 245 | 0.010 |
Why?
|
| Administration, Rectal | 1 | 1993 | 70 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1975 | 641 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1975 | 1139 | 0.010 |
Why?
|
| Prospective Studies | 4 | 2003 | 54419 | 0.010 |
Why?
|
| Cyclosporins | 1 | 1993 | 216 | 0.010 |
Why?
|
| Hepatitis B Antigens | 1 | 1973 | 38 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1995 | 564 | 0.010 |
Why?
|
| Capsules | 1 | 1993 | 191 | 0.010 |
Why?
|
| Testosterone | 1 | 2003 | 2472 | 0.010 |
Why?
|
| Bacteroides Infections | 1 | 1972 | 89 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1992 | 127 | 0.010 |
Why?
|
| Decarboxylation | 1 | 1971 | 7 | 0.010 |
Why?
|
| Endoscopy | 1 | 1982 | 1852 | 0.010 |
Why?
|
| Catechols | 1 | 1971 | 62 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1971 | 150 | 0.010 |
Why?
|
| Anaerobiosis | 1 | 1971 | 139 | 0.010 |
Why?
|
| Decision Trees | 1 | 1993 | 505 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1982 | 2189 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2003 | 3309 | 0.010 |
Why?
|
| Colorimetry | 1 | 1971 | 149 | 0.010 |
Why?
|
| Bilirubin | 1 | 1973 | 435 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1997 | 2927 | 0.010 |
Why?
|
| Propionates | 1 | 1971 | 181 | 0.010 |
Why?
|
| Placebos | 1 | 1975 | 1666 | 0.010 |
Why?
|
| Biological Transport | 1 | 1975 | 2082 | 0.010 |
Why?
|
| Karyotyping | 1 | 1992 | 1171 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 1544 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 1993 | 578 | 0.010 |
Why?
|
| Methylation | 1 | 1972 | 1070 | 0.010 |
Why?
|
| Parenteral Nutrition | 1 | 1993 | 659 | 0.000 |
Why?
|
| C-Reactive Protein | 1 | 2001 | 3821 | 0.000 |
Why?
|
| Macrophages | 2 | 1995 | 5754 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 12467 | 0.000 |
Why?
|
| Rectum | 1 | 1993 | 891 | 0.000 |
Why?
|
| Folic Acid | 1 | 1975 | 1323 | 0.000 |
Why?
|
| Hyperglycemia | 1 | 1997 | 1375 | 0.000 |
Why?
|
| Stress, Psychological | 1 | 2003 | 4488 | 0.000 |
Why?
|
| Follow-Up Studies | 2 | 2001 | 39121 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 2468 | 0.000 |
Why?
|
| Uremia | 1 | 1969 | 202 | 0.000 |
Why?
|
| Arthritis | 1 | 1973 | 681 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2010 | 41486 | 0.000 |
Why?
|
| Cross Infection | 1 | 1997 | 1422 | 0.000 |
Why?
|
| Streptococcal Infections | 1 | 1972 | 617 | 0.000 |
Why?
|
| Seizures | 1 | 1980 | 2965 | 0.000 |
Why?
|
| Species Specificity | 1 | 1971 | 2406 | 0.000 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1993 | 876 | 0.000 |
Why?
|
| Sex Factors | 1 | 2001 | 10552 | 0.000 |
Why?
|
| Iron | 1 | 1975 | 1790 | 0.000 |
Why?
|
| Length of Stay | 1 | 2000 | 6420 | 0.000 |
Why?
|
| Rheumatic Diseases | 1 | 1973 | 649 | 0.000 |
Why?
|
| Radiography | 3 | 1984 | 6975 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1973 | 2195 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1992 | 1767 | 0.000 |
Why?
|
| Incidence | 1 | 2003 | 21357 | 0.000 |
Why?
|
| Child | 2 | 2003 | 80134 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1995 | 4137 | 0.000 |
Why?
|
| Cell Survival | 1 | 1995 | 5776 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1997 | 9648 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1973 | 2839 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1971 | 2189 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 15308 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1992 | 6067 | 0.000 |
Why?
|
| Comorbidity | 1 | 1997 | 10514 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1995 | 11066 | 0.000 |
Why?
|
| Calcium | 1 | 1995 | 5720 | 0.000 |
Why?
|
| Age Factors | 1 | 1997 | 18385 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1971 | 4205 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1992 | 4744 | 0.000 |
Why?
|
| Hypertension | 1 | 1997 | 8537 | 0.000 |
Why?
|
| Dopamine | 2 | 1974 | 1606 | 0.000 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 1974 | 56 | 0.000 |
Why?
|
| Food Deprivation | 1 | 1974 | 114 | 0.000 |
Why?
|
| Ecology | 1 | 1974 | 104 | 0.000 |
Why?
|
| Diet | 1 | 1972 | 8047 | 0.000 |
Why?
|
| Tyramine | 1 | 1973 | 53 | 0.000 |
Why?
|
| Phenylacetates | 1 | 1973 | 111 | 0.000 |
Why?
|
| Heart Failure | 1 | 1997 | 11701 | 0.000 |
Why?
|
| Culture Media | 1 | 1973 | 894 | 0.000 |
Why?
|
| Intestine, Small | 1 | 1974 | 1207 | 0.000 |
Why?
|